News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News Zebra Technologies Introduces Smart, Non-Invasive Way for Hospitals to Track, Provide Real-Time Feedback on Patients with Acute Myocardial Infarction August 26, 2015